6 Evidence that insomnia can be a prodromal symptom in MDD7 suggests that sleep may be involved in the pathogenesis of depression. Chronic insomnia can also exist months or years before an episode of depression, and shares consistent clinical features, course, and response to treatment, as insomnia during M.DD. Thus, a recent National Institutes of Health conference suggested that “comorbid” insomnia may be a more appropriate term than “secondary.”8 selleck screening library depression is also overrepresented in individuals with sleep disorders.9 As many as Inhibitors,research,lifescience,medical 24% to 58% of individuals with sleep disordered breathing (eg, obstructive

sleep apnea) meet the criteria for depression.10-12 One general population survey of 18 980 adults reported that 0.8% of the sample had both sleep disordered breathing and MDD.13 As many as 18% of individuals diagnosed with M’DD also had sleep disordered breathing, and 17.6% of individuals with sleep disordered breathing were diagnosed with MDD. Patients with narcolepsy, Inhibitors,research,lifescience,medical a disorder characterized by excessive daytime sleepiness, similarly have elevated rates of depression; as many as 28% to 57%

have elevated depression symptoms,14,15 Inhibitors,research,lifescience,medical and in one sample, 20% met current or past criteria for depression.16 As many as three quarters of individuals with delayed sleep phase syndrome, a circadian rhythm disorder that, leads to secondary insomnia and negatively impacts daytime functioning, have a past

or current history of depression,17 and such individuals report, poorer sleep quality and more depression.18 Restless legs syndrome also has an increased association with depression19; as many as 53% of clinic patients with restless legs syndrome or periodic limb movements Inhibitors,research,lifescience,medical have elevated depression ratings.14,20 Insomnia is a risk factor for developing depression A number of longitudinal studies support the notion that insomnia is a risk factor for developing both first-onset and recurrent MDD. In the National Institute of Mental Health Epidemiologic Catchment, Area study sample (n=7954), individuals with persistent Inhibitors,research,lifescience,medical insomnia (present at both baseline and 1-year follow-up) were much more likely to develop a new depressive episode at follow-up compared with individuals whose insomnia resolved by follow-up (odds ratio (OR)=39.8,95% confidence interval (CI)=19.8-80.0 vs OR=1.6, 95% CI=0.5-5.3).21 Subsequent analyses22 revealed mafosfamide that of all the symptoms of depression, sleep problems were the most, prevalent, (13.6%), and those with sleep problems had the highest, relative odds (7.6 times) of developing a new-onset major depressive episode during the next year compared with those without sleep problems. Sleep problems also identified 47% of individuals who develop depression in the following year, more than any other depression symptom. Thus, us, sleep problems had the strongest predictive value of who would develop MDD.